Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial
- Sylvie Lorenzen
- Thorsten Oliver Goetze
- Peter C. Thuss-Patience
- Jorge Riera-Knorrenschild
- Eray Goekkurt
- Tobias Nicolaas Dechow
- Thomas Jens Ettrich
- Ralf Dieter Hofheinz
- Kim Barbara Luley
- Daniel Pink
- Udo Lindig
- Gunnar Folprecht
- Gunter Schuch
- Michael Bitzer
- Volker Heinemann
- Stefan Angermeier
- Claus Bolling
- Maria Loose
- Sabine Junge
- Claudia Pauligk
- Salah-Eddin Al-Batran
2026-04-17